Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Beginning January 1, pharmacists can provide an initial supply of the pills that prevent HIV.
This is one of several lawsuits filed by advocates on behalf of inmates with the liver virus in U.S. prisons.
The Trump administration had proposed changing which meds were covered, including HIV and cancer drugs.
Stop me if you’ve heard this one before.
The patient advocacy coalition I Am Essential sent a letter to the HHS spelling out why the plan is dangerous.
Thus far, no state prison systems have adopted the protocols that advocates are demanding.
Unlike the uptick seen in some other cities, this one isn’t fueled by opioids.
The settlement ensures all affected state prisoners will be treated for the disease.
The ambitious plan will allocate an initial $5 million to help ramp up treatment, remove barriers to care and increase harm reduction.
Health coalition warns the federal government: People with chronic or serious conditions face growing costs at the pharmacy.
Most cite high prices as the reason for denying treatment.
Medi-Cal will soon begin providing treatment access to almost all state-insured patients living with the virus.
More proof that filing treatment access lawsuits can pay off for people with HCV.
States will be able to more easily design programs to increase access to treatment for substance use disorders.
Last week, the president announced that biosimilar drugs would no longer get special incentives on state Medicaid markets.
A new analysis published in The American Journal of Managed Care further slams state policies restricting HCV treatment.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.